Tuesday, October 5, 2021

Every Lap Run Under Caution During NASCAR Will Now Aid In Making Strides Against Breast Cancer


During October, Chevy will begin supporting the American Cancer Society with a contribution of $350 for every NASCAR lap run under caution, adding a charitable element to the three NASCAR Cup Series races scheduled to take place.

The Camaro ZL1 has long been a track-ready and fine-tuned machine, and a unique pink “Making Strides Against Breast Cancer” model will serve as the pace car at the NASCAR Cup Series races at Talledega Superspeedway, Texas Motor Speedway, and Martinsville Speedway this October. The crowd response during these action-packed races has always been amazingly positive, and this is the 11th year in a row that Chevy has partnered with the American Cancer Society. We know how powerful the strength in numbers is when it comes to fighting cancer, and Chevy will also make the effort to donate $5 toward the fight against breast cancer this month with every post on Twitter, Instagram, and Tik Tok that uses the hashtag #WeDriveFor. 


This Camaro that is now instrumental in fighting this tragic disease is powered by a supercharged 6.2-liter V8. When paired with the 6-speed manual transmission or available 10-speed automatic, the small-block V8 has the capability to clock amazing performance and possess legendary force on the dragstrip. With a well-balanced rear-drive chassis and can stop from 70 mph in 143 feet, the ZL1’s brakes are top-of-the-line. 

Standard equipment on the ZL1 includes power-adjustable front seats with heating and ventilation, a heated steering wheel, dual-zone automatic climate control, a Bose audio system, wireless phone charging, and a head-up display. A smooth ride, good value, and potent acceleration are traits that set the ZL1 apart. This car that has now stepped up to the plate to fight to keep families healthy and reveling in early detection of this disease has always displayed the best traits of Detroit muscle, and supreme performance on the strip!


No comments:

Post a Comment